Infection of human cell lines and primary hepatocytes can be blocked by specific antibodies directed against CLDN1 [89,145] and kinetics of inhibition with such antibodies showed that CLDN1 acts cooperatively with CD81 and SR-BI in HCV entry [89]. This evidence concerns the gene CLDN1 and infection.